The ASCO Post Podcast

IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development

12 Jul 2023

Contributed by Lukas

This week, we’re again focusing on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Ca...

IASLC WCLC 2020: Updates From the ADAURA Trial and More

12 Jul 2023

Contributed by Lukas

This week, we’re hearing from two thoracic oncologists on research presented at the International Association for the Study of Lung Cancer 2020 Worl...

Prevalence of KRAS G12C Mutations Across Different Populations

12 Jul 2023

Contributed by Lukas

This week, we’ll discuss the findings of a study that examined the prevalence of KRAS G12C mutations across different populations. Then, we’ll hea...

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

12 Jul 2023

Contributed by Lukas

This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesop...

Findings From the 2021 Gastrointestinal Cancers Symposium

12 Jul 2023

Contributed by Lukas

The 2021 Gastrointestinal Cancers Symposium, held in a virtual format this year, is being held this weekend, January 15th to 17th, 2021. We’re discu...

IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer

12 Jul 2023

Contributed by Lukas

This week, we’ll review a meta-analysis of several trials studying the efficacy of 3 vs 6 months of adjuvant chemotherapy for patients with advanced...

News From the 2020 San Antonio Breast Cancer Symposium

12 Jul 2023

Contributed by Lukas

The San Antonio Breast Cancer Symposium took place virtually from December 8 to 12th. This week, we’re featuring three important studies from the me...

More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More

12 Jul 2023

Contributed by Lukas

This week, we’ll focus further on studies presented at the 2020 ASH Annual Meeting & Exposition, including findings on the use of whole-genome s...

News From the 2020 ASH Annual Meeting & Exposition

12 Jul 2023

Contributed by Lukas

The 2020 ASH Annual Meeting & Exposition, held in a virtual format this year, begins today. We’re featuring three studies on the podcast this we...

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

12 Jul 2023

Contributed by Lukas

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first ...

Immune-Related Adverse Events and Survival Outcomes in NSCLC

12 Jul 2023

Contributed by Lukas

This week, we’re focusing on lung cancer—first, with a report on how therapy-related adverse events experienced by patients with lung cancer treat...

Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting

12 Jul 2023

Contributed by Lukas

This week, we're focusing on high-impact research in prostate cancer presented during the virtual 2020 ASTRO Annual Meeting. The studies included a fo...

2020 ASTRO Annual Meeting: High-Impact Research

12 Jul 2023

Contributed by Lukas

This week, we’ll be featuring discussions of two late-breaking abstracts presented during the virtual 2020 American Society for Radiation Oncology, ...

Recent FDA Approvals in Leukemia and Lymphoma

12 Jul 2023

Contributed by Lukas

This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively.Cover...

First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC

12 Jul 2023

Contributed by Lukas

This week, we’ll review results of a trial that evaluated first-line anti–PD-L1 therapy vs platinum-based chemotherapy in patients with metastatic...

Breast Cancer News From the ESMO Virtual Congress 2020

12 Jul 2023

Contributed by Lukas

This week, we’ll be featuring our last disease-specific roundup from the ESMO Virtual Congress 2020. We’ll hear from three experts on their findin...

Lung Cancer Reports From the ESMO Virtual Congress 2020

12 Jul 2023

Contributed by Lukas

This week, we’ll be reviewing results from several reports on lung cancer presented during the ESMO Virtual Congress 2020. The findings focus on the...

ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

12 Jul 2023

Contributed by Lukas

This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the resear...

ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers

12 Jul 2023

Contributed by Lukas

This weekend, the ESMO Virtual Congress 2020 is underway, and we’re sharing interviews with two authors of high-impact papers on breast cancer and h...

Veliparib Plus Carboplatin/Paclitaxel in BRCA-Mutated, HER2-Negative Advanced Breast Cancer

12 Jul 2023

Contributed by Lukas

We’ll discuss the efficacy of a triplet combination therapy in BRCA-mutated, HER2-negative advanced breast cancer. Then, we’ll move on to a report...

From the Archive: Insights on Young-Onset Colorectal Cancer

12 Jul 2023

Contributed by Lukas

Due to the unexpected passing of actor Chadwick Boseman on August 28, there has been a renewed interest in young-onset colorectal cancer. Mr. Boseman,...

Highlights From the IASLC Virtual Presidential Symposium

12 Jul 2023

Contributed by Lukas

This week on The ASCO Post Podcast, we'll first hear about a study of the monoclonal antibody sintilimab in combination with pemetrexed and platinum t...

Decline in Non–Small Cell Lung Cancer Mortality From 2013 to 2016

12 Jul 2023

Contributed by Lukas

We’ll first hear about a study that found a steep decline in non–small cell lung cancer mortality from 2013 to 2016. Then, we’ll close out with ...

Pathologic Complete Response in the I-SPY2 Trial

12 Jul 2023

Contributed by Lukas

This week, we’ll start with a follow-up analysis of pathologic complete response in patients participating in the I-SPY2 trial. Then, we’ll move o...

New Guidelines on Cervical Cancer Screening

12 Jul 2023

Contributed by Lukas

This week, we’ll review recommendations from a new guideline issued by the American Cancer Society on cervical cancer screening. Then, we’ll discu...

Comparison of Two Combination Treatments in Localized Pancreatic Cancer

12 Jul 2023

Contributed by Lukas

This week, we’ll discuss a study that compared two combination treatments for previously untreated patients with localized pancreatic cancer. Then, ...

Cabozantinib for Patients With Advanced Bladder Cancer

12 Jul 2023

Contributed by Lukas

This week, we’ll discuss phase II results on cabozantinib in patients with advanced bladder cancer. Then, we’ll review a study on behaviors relate...

Lenvatinib Plus Pembrolizumab for Patients With Advanced Gastric Cancer

12 Jul 2023

Contributed by Lukas

This week, we’ll discuss the efficacy of the combination of lenvatinib and pembrolizumab for patients with advanced gastric cancer. We’ll also hig...

Spotlight on Two Breast Cancer Studies From the ASCO20 Virtual Scientific Program

12 Jul 2023

Contributed by Lukas

This week, we’ll review two influential breast cancer studies presented during the ASCO20 Virtual Scientific Program: MINDACT and HER2CLIMB."}" data...

Multiple Myeloma Research From the ASCO20 Virtual Scientific Program

12 Jul 2023

Contributed by Lukas

This week, we’ll be hearing from the presenters of three abstracts focused on multiple myeloma presented during the ASCO20 Virtual Scientific Progra...

COVID-19 Research From the ASCO20 Virtual Scientific Program

12 Jul 2023

Contributed by Lukas

With this week bringing record highs of COVID-19 infection across the nation, we’re revisiting two presentations from the ASCO20 Virtual Scientific ...

Findings in Prostate Cancer From the ASCO20 Virtual Scientific Program

12 Jul 2023

Contributed by Lukas

We're hearing from the authors of three high-impact papers on research in prostate cancer presented during the ASCO20 Virtual Scientific Program."}" d...

Plenary Research From the ASCO20 Virtual Scientific Program: Part 2

12 Jul 2023

Contributed by Lukas

This week, we’ll review two late-breaking abstracts from the ASCO20 Virtual Scientific Program that reported negative results. Both were presented d...

Plenary Research From the ASCO20 Virtual Scientific Program: Part 1

12 Jul 2023

Contributed by Lukas

This week, we’ll be hearing from the authors of three late-breaking abstracts presented in the Plenary program at the ASCO20 Virtual Scientific Prog...

Coagulation Issues in Patients With COVID-19: Part 2

11 Jul 2023

Contributed by Lukas

In part 2 of our conversation with Dr. Syed Abutalib, Associate Director of the Hematology and Cellular Therapy Program and Director of the Clini...

Coagulation Issues in Patients With COVID-19: Part 1

11 Jul 2023

Contributed by Lukas

This week, we spoke with Dr. Syed Abutalib, Associate Director of the Hematology and Cellular Therapy Program and Director of the Clinical Apheresis P...

Highlights From the AACR Virtual Annual Meeting

11 Jul 2023

Contributed by Lukas

This week, we’ll be featuring some research highlights from the AACR Virtual Annual Meeting, including data on a triplet regimen for women with high...

Does Ibrutinib Offer a Protective Effect Against Pulmonary Injury in Patients With COVID-19?

11 Jul 2023

Contributed by Lukas

This week, we’ll start off with a report that showed that ibrutinib may help to protect patients infected with COVID-19 from pulmonary injury due to...

Recent FDA Oncology/Hematology Approvals

11 Jul 2023

Contributed by Lukas

The U.S. Food and Drug Administration (FDA) had a very busy 10 or so days, so this week, we’ll go over five recent oncology and hematology approvals...

Characteristics and Outcomes of Patients With Both COVID-19 and Cancer

11 Jul 2023

Contributed by Lukas

To begin this week, we’ll discuss a report that focused on the characteristics and outcomes of patients with both COVID-19 and cancer in Wuhan, Chin...

Report on the ASH COVID-19 Registry for Malignant Hematology

11 Jul 2023

Contributed by Lukas

We begin with an interview with Dr. William A. Wood of the University of North Carolina, Chapel Hill. Dr. Wood is current Chair of the ASH Resear...

End-of-Trial Findings From CLEOPATRA

11 Jul 2023

Contributed by Lukas

This week, we’ll start with a report on end-of-trial findings with a triplet combination treatment for HER2-positive metastatic breast cancer. Then,...

Cancer Care Amid the COVID-19 Pandemic

11 Jul 2023

Contributed by Lukas

To start off this week, we’ll discuss a report from physicians in Washington state about how they’re handling cancer care currently in their insti...

Coronavirus, Patients With Cancer, and the Preparedness of the Institutions That Care for Them

11 Jul 2023

Contributed by Lukas

We're covering the topic on everyone’s minds—coronavirus. We’ll start with the state of the epidemic as it relates to patients with cancer ...

Pulmonary Pathology of the Novel Coronavirus in Two Patients With Lung Cancer

11 Jul 2023

Contributed by Lukas

We’ll begin this week by discussing an article that described the pulmonary pathology of the novel coronavirus, or COVID-19, which was found coincid...

News From the 2020 Multidisciplinary Head and Neck Cancers Symposium

11 Jul 2023

Contributed by Lukas

This week, we’ll hear from two researchers on findings presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium. We’ll also review ...

News From the Genitourinary Cancers Symposium

11 Jul 2023

Contributed by Lukas

This week, we’ll be reviewing data from three influential abstracts presented at the recent 2020 Genitourinary Cancers Symposium in San Francisco—...

Pembrolizumab Plus Chemotherapy in HER2-Negative Breast Cancer

11 Jul 2023

Contributed by Lukas

We’ll start off by discussing results from the I-SPY 2 trial on the efficacy of pembrolizumab plus chemotherapy in HER2-negative breast cancer. Then...

H. pylori Infection and Gastric Cancer Risk

11 Jul 2023

Contributed by Lukas

First, we’ll discuss a Korean trial that looked at the role of H. pylori infection and gastric cancer risk. Next, we’ll turn to a modeling study t...

BEACON CRC: Patient-Reported Quality of Life Results

11 Jul 2023

Contributed by Lukas

This week, we’ll be featuring three researchers discussing findings presented at the 2020 Gastrointestinal Cancers Symposium: Dr. Scott Kopetz,...

News From the Gastrointestinal Cancers Symposium

11 Jul 2023

Contributed by Lukas

The 2020 Gastrointestinal Cancers Symposium took place last weekend, and today, we’ll take a deeper dive into findings in pancreatic cancer and colo...

Elevations in Cancer Incidence Among Responders to the WTC Site After the September 11 Attacks

11 Jul 2023

Contributed by Lukas

We’ll begin with a study that focused on elevations in cancer incidence among responders to the World Trade Center site after the September 11, 2001...

Impact of Time of Day of Immune Checkpoint Inhibitor Infusion on Overall Survival in Advanced Melanoma

11 Jul 2023

Contributed by Lukas

On this episode, we’ll hear about a study that examined the impact of the time of day that a patient with advanced melanoma receives an immune check...

Recent Approvals From the FDA

10 Jul 2023

Contributed by Lukas

The FDA certainly had a busy December, and this week, we’ll be reviewing some recent approvals: olaparib for germline BRCA-mutated metastatic pancre...

News From the San Antonio Breast Cancer Symposium

10 Jul 2023

Contributed by Lukas

In this episode, we’ll cover three important presentations from the San Antonio Breast Cancer Symposium. The first reports results from the HER2CLIM...

Plenary Presentations From the 2019 ASH Annual Meeting & Exposition

10 Jul 2023

Contributed by Lukas

On this episode, we hear from the authors of three high-impact abstracts presented at the 2019 ASH Annual Meeting & Exposition. The first paper in...

Sequence of Therapies for Metastatic Castration-Resistant Prostate Cancer

10 Jul 2023

Contributed by Lukas

We’ll start with a trial focused on the sequence of therapies for metastatic, castration-resistant prostate cancer. Then, we’ll move on to an abst...

Reports From the ESMO Asia Congress 2019

10 Jul 2023

Contributed by Lukas

This week, we summarize two studies presented at the recent ESMO Asia Congress—one on a novel combination therapy for unresectable liver cancer, and...

Nivolumab Plus Bevacizumab for Relapsed Ovarian Cancer

10 Jul 2023

Contributed by Lukas

According to findings from a phase II trial, the combination of nivolumab and bevacizumab has shown activity in relapsed ovarian cancer—we discuss t...

ADMIRAL Trial of Gilteritinib vs Salvage Chemotherapy in FLT3-Mutated Acute Myeloid Leukemia

10 Jul 2023

Contributed by Lukas

The ADMIRAL trial evaluated gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia—we'll discuss recently reported overall surv...

Addition of Durvalumab to Etoposide Plus Platinum Chemotherapy for Extensive-Stage SCLC

10 Jul 2023

Contributed by Lukas

This week, we’ll review an interim analysis of the CASPIAN trial, which evaluated the addition of durvalumab to etoposide plus platinum chemotherapy...

Gastrointestinal Cancer Research From ESMO 2019

10 Jul 2023

Contributed by Lukas

This week, we discuss two studies in gastrointestinal cancers presented at this year’s European Society for Medical Oncology Congress. First up, the...

News in Genitourinary Cancers From ESMO 2019

10 Jul 2023

Contributed by Lukas

This week, we discuss two studies in genitourinary cancers presented at the ESMO Congress 2019. The CARD trial investigated treatment with cabazitaxel...

Selected Breast Cancer Abstracts From ESMO 2019

10 Jul 2023

Contributed by Lukas

This week, we’ll be discussing selected breast cancer abstracts presented at the ESMO Congress 2019, including the MONALEESA-3 and MONARCH-2 st...

Lung Cancer Research Highlights From ESMO 2019

10 Jul 2023

Contributed by Lukas

This week, we’ll be discussing research highlights in lung cancer presented at the ESMO Congress 2019, including the FLAURA trial of osimertinib in ...

News in Ovarian Cancer From ESMO 2019

10 Jul 2023

Contributed by Lukas

This week, we review two studies from a Presidential Symposium at ESMO focusing on the efficacy of PARP inhibitors in patients with newly diagnosed ov...

Benefit of Daratumumab Across Populations With Newly Diagnosed Multiple Myeloma

10 Jul 2023

Contributed by Lukas

This week, we review a presentation on the benefit of daratumumab across populations with newly diagnosed multiple myeloma. We also talk about a study...

News From the ASTRO Annual Meeting

10 Jul 2023

Contributed by Lukas

This week, we’ll be going over news from the ASTRO Annual Meeting, including an analysis of the effect of long-term hormonal therapy on men with low...

News From the IASLC World Conference on Lung Cancer and the ASCO Quality Care Symposium

10 Jul 2023

Contributed by Lukas

This week, we’ll be discussing findings presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lun...

First-Line Nivolumab and Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma

10 Jul 2023

Contributed by Lukas

This week, we’ll be talking about an extended follow-up of a phase III trial that investigated first-line nivolumab and ipilimumab vs sunitinib in a...

Pooled Survival Analysis of Patients With NSCLC Treated With Nivolumab

10 Jul 2023

Contributed by Lukas

This week, we review a pooled analysis of long-term survival rates in patients with previously treated non–small cell lung cancer treated with nivol...

USPSTF Recommendation Against Pancreatic Cancer Screening in Asymptomatic Adults

10 Jul 2023

Contributed by Lukas

This week, we review the U.S. Preventive Services Task Force (USPSTF) recommendation against screening for pancreatic cancer in adults with no sy...

Ibrutinib and Rituximab vs Standard Chemoimmunotherapy in CLL

10 Jul 2023

Contributed by Lukas

This week, we review a report on the combination of ibrutinib and rituximab vs standard chemoimmunotherapy in some patients with chronic lymphocytic l...

Erdafitinib for FGFR-Altered Advanced Urothelial Carcinoma

10 Jul 2023

Contributed by Lukas

This week, we review a phase II trial of erdafitinib in urothelial carcinoma with an FGFR alteration. We also talk about a report from the World Healt...

Overall Survival in MONALEESA-7

07 Jul 2023

Contributed by Lukas

This week, we discuss an interim analysis of the MONALEESA-7 trial of the addition of ribociclib to endocrine therapy in pre- or perimenopausal women ...

Rates of Early-Onset Colorectal Cancer

07 Jul 2023

Contributed by Lukas

This week, we discuss a study that found a disconnect between rates of colonoscopy and recent increases in colorectal cancer incidence in younger adul...

Long-Term Results From the National Lung Screening Trial

07 Jul 2023

Contributed by Lukas

This week, we discuss long-term results from an extended analysis of the National Lung Screening Trial, and Dr. James Mulshine of Rush University...

ESMO World GI: Findings From the BEACON CRC Trial and More

07 Jul 2023

Contributed by Lukas

We discuss two studies on colorectal cancer that were presented at the ESMO World Congress on Gastrointestinal Cancer. We also talk about a recently p...

ICML 2019: Role of Liquid Biopsy in Lymphoma

07 Jul 2023

Contributed by Lukas

In this episode, The ASCO Post's Editor-in-Chief Dr. James Armitage talks about the International Conference on Malignant Lymphoma (ICML), which ...

CASSIOPEIA Trial in Multiple Myeloma

07 Jul 2023

Contributed by Lukas

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at...

2019 ASCO: Resection of Liver Metastases

07 Jul 2023

Contributed by Lukas

In this episode, we discuss more news from the ASCO Annual Meeting, including findings from a study with relevance to surgical oncology, a s...

2019 ASCO: Pancreatic, Urothelial, and Cervical Cancers

05 Jul 2023

Contributed by Lukas

In this episode, we discuss more news from the ASCO Annual Meeting, sharing interviews with experts on studies in pancreatic, urothelial, and cervical...

Updates in the Surgical Management of Breast Cancer

05 May 2023

Contributed by Lukas

This week, we’re hearing from three experts on recent data focusing on the surgical management of breast cancer. All three speakers presented these ...

More From the AACR Annual Meeting 2023: Novel Therapeutics, Immunotherapy for Liver Cancer, and More

28 Apr 2023

Contributed by Lukas

https://ascopost.com/podcasts/This week, we present reports on four important presentations made during the American Association for Cancer Research (...

Highlights From the AACR Annual Meeting 2023

21 Apr 2023

Contributed by Lukas

On this episode, we are sharing news presented during the American Association for Cancer Research (AACR) Annual Meeting, which was held earlier this ...

NCCN 2023 Annual Conference: Quality of Life Issues

14 Apr 2023

Contributed by Lukas

The National Comprehensive Cancer Network, or NCCN, held its annual meeting recently in Orlando. On this week’s episode of The ASCO Post podcast, we...

Highlights From the NCCN 2023 Annual Conference

07 Apr 2023

Contributed by Lukas

The National Comprehensive Cancer Network, or NCCN, held its annual meeting recently in Orlando. On this week’s episode, we’ll hear from two of th...

RUBY Trial in Endometrial Cancer and Breast Cancer Screening After Treatment

31 Mar 2023

Contributed by Lukas

On this episode, we discuss two important studies presented over the past month at two oncology meetings, including the Society of Gynecologic Oncolog...

Highlights From the SSO 2023 International Conference on Surgical Cancer Care

24 Mar 2023

Contributed by Lukas

On this episode, we discuss two studies that were presented at the Society of Surgical Oncology (SSO) 2023 International Conference on Surgical Cancer...

Colorectal Cancer Awareness Month: Spotlight on Recent Research in Gastrointestinal Oncology

17 Mar 2023

Contributed by Lukas

On this episode, we are recognizing colorectal cancer awareness month with two news items pertaining to gastrointestinal oncology reported over the pa...

2023 ASCO Genitourinary Cancers Symposium: Focus on Bladder Cancer

10 Mar 2023

Contributed by Lukas

On this week’s episode, we’re continuing our coverage of data presented at the 2023 ASCO Genitourinary Cancers Symposium in San Francisco. Daniel ...

2023 ASCO Genitourinary Cancers Symposium: Focus on Prostate Cancer

03 Mar 2023

Contributed by Lukas

On this episode, we’re continuing our coverage of data presented at the 2023 ASCO Genitourinary Cancers Symposium, which took place recently in San ...

2023 ASCO Genitourinary Cancers Symposium: Focus on RCC

24 Feb 2023

Contributed by Lukas

On this episode, we’re sharing news from our coverage of data presented at the 2023 ASCO Genitourinary Cancers Symposium, which took place recently ...

Recent FDA Approvals for Patients With Breast Cancer

14 Feb 2023

Contributed by Lukas

On this episode, we’re reviewing two recent U.S. Food and Drug Administration (FDA) approvals for patients with breast cancer: the February 3 approv...

Highlights From the 2023 ASCO Gastrointestinal Cancers Symposium

03 Feb 2023

Contributed by Lukas

The 2023 ASCO Gastrointestinal Cancers Symposium took place from January 19 to 21 in San Francisco. On this episode, we’re hearing from the presenti...

Sotorasib in Previously Treated Patients With KRAS G12C–Mutated Advanced Pancreatic Cancer: In Conversation With The ASCO Post

27 Jan 2023

Contributed by Lukas

On this episode, Chandrakanth Are, MBBS, MBA, FSSO, FRCS, FACS, Professor of Surgical Oncology and Global Health at University of Nebraska Medical Cen...

2022 ASH Annual Meeting and Exposition: Focus on Lymphoma

20 Jan 2023

Contributed by Lukas

On this episode, we’re continuing our coverage of research presented at the 2022 ASH Annual Meeting and Exposition. Today, we’ll hear from several...

2022 ASH Annual Meeting and Exposition: Focus on Multiple Myeloma

13 Jan 2023

Contributed by Lukas

On this episode, we’re continuing our coverage of research presented at the 2022 ASH Annual Meeting and Exposition. Today, we’ll hear from several...

2022 ASH Annual Meeting and Exposition: Focus on Leukemia

06 Jan 2023

Contributed by Lukas

On this episode, we’re featuring authors discussing their impactful research presented at the 2022 ASH Annual Meeting and Exposition, focusing on fi...

Highlights From the 2022 San Antonio Breast Cancer Symposium

16 Dec 2022

Contributed by Lukas

This year’s San Antonio Breast Cancer Symposium took place last week. On this episode, we’re hearing from the authors of three high-impact studies...